{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:58:02Z","timestamp":1793451482496,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.biologicals.2005.11.010","type":"journal-article","created":{"date-parts":[[2006,2,24]],"date-time":"2006-02-24T07:20:56Z","timestamp":1140765656000},"page":"281-288","source":"Crossref","is-referenced-by-count":37,"title":["Characterisation of a novel high-purity, double virus inactivated von Willebrand Factor and Factor VIII concentrate (Wilate\u00ae)"],"prefix":"10.1016","volume":"34","author":[{"given":"M.","family":"Stadler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kannicht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Biesert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.U.","family":"Radomski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Suhartono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Pock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Neisser-Svae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Weinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"R\u00f6misch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.-E.","family":"Svae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2005.11.010_bib1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.biochem.67.1.395","article-title":"Biochemistry and genetics of von Willebrand factor","volume":"67","author":"Sadler","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.biologicals.2005.11.010_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0037-1619601","article-title":"Platelet and von Willebrand factor interactions at the vessel wall","volume":"24","author":"Ruggeri","year":"2004","journal-title":"Haemostaseol"},{"key":"10.1016\/j.biologicals.2005.11.010_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF02981974","article-title":"Functional property of von Willebrand Factor under flowing blood","volume":"75","author":"Sugimoto","year":"2002","journal-title":"Int J Hematol"},{"key":"10.1016\/j.biologicals.2005.11.010_bib4","first-page":"232","article-title":"Factor VIII \u2013 novel insights into form and function","volume":"119","author":"Tuddenham","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.biologicals.2005.11.010_bib5","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-0037-1613992","article-title":"Impact, diagnosis and treatment of von Willebrand disease","volume":"84","author":"Sadler","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.biologicals.2005.11.010_bib6","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood.V70.4.895.895","article-title":"von Willebrand factor and von Willebrand disease","volume":"70","author":"Ruggeri","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.biologicals.2005.11.010_bib7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-0037-1619607","article-title":"Current treatment of von Willebrand's disease","volume":"24","author":"Ingerslev","year":"2004","journal-title":"Haemostaseol"},{"key":"10.1016\/j.biologicals.2005.11.010_bib8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2516.2004.00893.x","article-title":"A comparative in vitro evaluation of six von Willebrand factor concentrates","volume":"10","author":"Lethagen","year":"2004","journal-title":"Haemophilia"},{"key":"10.1016\/j.biologicals.2005.11.010_bib9","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1055\/s-0037-1613027","article-title":"A comparative multi-laboratory assessment of three factor VIII\/von Willebrand factor concentrates","volume":"87","author":"Favaloro","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.biologicals.2005.11.010_bib10","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1182\/blood.V83.10.3018.3018","article-title":"Proteolysis of von Willebrand Factor in therapeutic plasma concentrates","volume":"10","author":"Mannucci","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.biologicals.2005.11.010_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ajh.2830310108","article-title":"Characterisation of von Willebrand factor in factor VIII concentrates","volume":"31","author":"Fricke","year":"1989","journal-title":"Am J Hematol"},{"key":"10.1016\/j.biologicals.2005.11.010_bib12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3109\/07853890009002024","article-title":"Viral safety of hemophilia treatment products","volume":"32","author":"Teitel","year":"2000","journal-title":"Ann Med"},{"issue":"Suppl. 1","key":"10.1016\/j.biologicals.2005.11.010_bib13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1423-0410.1998.tb05474.x","article-title":"Solvent\/detergent treatment of human plasma \u2013 a very robust method for virus inactivation. Validated virus safety for OCTAPLAS","volume":"74","author":"Biesert","year":"1998","journal-title":"Vox Sang"},{"key":"10.1016\/j.biologicals.2005.11.010_bib14","unstructured":"Pharm. Eur. Near infrared spectrophotometry. 4th ed. 2002. 2.2.40.1.1."},{"key":"10.1016\/j.biologicals.2005.11.010_bib15","first-page":"227","article-title":"The method of \u201cright or wrong cases\u201d (constant stimuli) without Gauss's formulae","volume":"2","author":"Spearman","year":"1908","journal-title":"Br J Psychol"},{"key":"10.1016\/j.biologicals.2005.11.010_bib16","first-page":"4742","article-title":"Bekanntmachung \u00fcber die Zulassung von Arzneimittel: Anforderungen an Validierungsstudien zum Nachweis der Virussicherheit von Arzneimitteln aus menschlichem Blut oder Plasma","author":"Bundesgesundheitsamt und Paul-Ehrlich-Institut","year":"04051994","journal-title":"Bundesanzeiger vom"},{"key":"10.1016\/j.biologicals.2005.11.010_bib17","unstructured":"Pharm. Eur. 4th ed. 2002, 2.7.4. Human coagulation factor VIII."},{"key":"10.1016\/j.biologicals.2005.11.010_bib18","unstructured":"Pharm. Eur. Human coagulation factor VIII. 4th ed. 2002, 2.7.5. Supplement 4.2."},{"issue":"4","key":"10.1016\/j.biologicals.2005.11.010_bib19","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1055\/s-0038-1657727","article-title":"von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic use","volume":"78","author":"Murdock","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.biologicals.2005.11.010_bib20","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1055\/s-0037-1613226","article-title":"Standardisation of von Willebrand Factor in therapeutic concentrates: calibration of the 1st International Standard for von Willebrand Factor concentrate (00\/514)","volume":"88","author":"Hubbard","year":"2002","journal-title":"Thromb Haemost"},{"issue":"Suppl. 3","key":"10.1016\/j.biologicals.2005.11.010_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-2516.1998.0040s3025.x","article-title":"Characterization of factor VIII\/von Willebrand factor concentrates using a modified method of von Willebrand factor multimer analysis","volume":"4","author":"Metzner","year":"1998","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.biologicals.2005.11.010_bib22","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1365-2141.1990.tb02655.x","article-title":"Clinical and laboratory evaluation of National Health Service factor VIII concentrate (8Y) for the treatment of von Willebrand's disease","volume":"75","author":"Cumming","year":"1990","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.biologicals.2005.11.010_bib23","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1182\/blood.V99.2.450","article-title":"Alphanate Study Group. Treatment of von Willebrand disease with a high-purity factor VIII\/von Willebrand factor concentrate: a prospective, multicenter study","volume":"99","author":"Mannucci","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.biologicals.2005.11.010_bib24","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1172\/JCI114107","article-title":"Molecular basis of Factor VIII inhibition by human antibodies","volume":"83","author":"Arai","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.biologicals.2005.11.010_bib25","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1073\/pnas.86.11.4277","article-title":"Direct characterisation of Factor VIII in plasma; Detection of a mutation altering a thrombin cleavage site (arginine-372\u2192histidine)","volume":"86","author":"Arai","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biologicals.2005.11.010_bib26","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1021\/bi00337a007","article-title":"Purification of human factor VIII:C and its characterisation by western blotting using monoclonal antibodies","volume":"24","author":"Rotblat","year":"1985","journal-title":"Biochemistry"},{"key":"10.1016\/j.biologicals.2005.11.010_bib27","first-page":"3241","article-title":"Hemophilia A and parahemophilia: deficiencies and coagulation Factors VIII and V","volume":"vol. III","author":"Kazazian","year":"1995"},{"key":"10.1016\/j.biologicals.2005.11.010_bib28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000205234","article-title":"Rapid physiological coagulation method in determination of fibrinogen","volume":"4","author":"Clauss","year":"1957","journal-title":"Acta Haematol"},{"key":"10.1016\/j.biologicals.2005.11.010_bib29","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1001\/archinte.1976.03630090048011","article-title":"Haemolysis caused by factor VIII concentrates","volume":"136","author":"Orringer","year":"1976","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.biologicals.2005.11.010_bib30","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s002770050184","article-title":"von Willebrand factor: molecular size and functional activity","volume":"72","author":"Furlan","year":"1996","journal-title":"Ann Hematol"},{"key":"10.1016\/j.biologicals.2005.11.010_bib31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00320748","article-title":"Hemostatic effect of a heat-treated factor VIII concentrate (Haemate P) in von Willebrand's disease","volume":"56","author":"Fukui","year":"1988","journal-title":"Blut"},{"key":"10.1016\/j.biologicals.2005.11.010_bib32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ajh.2830250106","article-title":"Correction of the bleeding time in treated patients with severe von Willebrand disease is not solely dependent on the normal multimeric structure of plasma von Willebrand factor","volume":"25","author":"Mannucci","year":"1987","journal-title":"Am J Hematol"},{"key":"10.1016\/j.biologicals.2005.11.010_bib33","doi-asserted-by":"crossref","first-page":"7503","DOI":"10.1073\/pnas.90.16.7503","article-title":"Triplet structure of von Willebrand factor reflects proteolytic degradation of high molecular weight multimers","volume":"90","author":"Furlan","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biologicals.2005.11.010_bib34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1600-0609.1999.tb01740.x","article-title":"Selectivity of von Willebrand factor triplet bands towards heparin binding supports structural model","volume":"62","author":"Fischer","year":"1999","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.biologicals.2005.11.010_bib35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1365-2516.1998.0040s3007.x","article-title":"Optimizing therapy with factor FVIII\/von Willebrand factor concentrates in von Willebrand disease","volume":"4","author":"Frederici","year":"1998","journal-title":"Haemophilia"},{"key":"10.1016\/j.biologicals.2005.11.010_bib36","first-page":"A73","article-title":"Clinical efficacy and safety of Wilate\u00ae, a novel, high-purity VWF\/FVIII concentrate with double virus inactivation and optimised pharmacokinetic properties in the treatment of von Willebrand disease","volume":"25","author":"Windyga","year":"2005","journal-title":"Haemostaseol"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105605001314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105605001314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T18:18:53Z","timestamp":1586715533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105605001314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S1045105605001314"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2005.11.010","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}